What did Blackstone, Carlyle and Hellman & Friedman pay for Medline Industries?

Blackstone, Carlyle and Hellman & Friedman acquired Medline Industries for $34.00B in 2021 (15.5x EBITDA), equivalent to 1.70x revenue. Target revenue was approximately $20200.0M. Target EBITDA was approximately $2200.0M.

What does Medline Industries do?

Medline Industries is a medical devices business.

What multiple did Blackstone, Carlyle and Hellman & Friedman pay for Medline Industries?

15.5x EBITDA and 1.70x revenue, based on disclosed deal value of $34.00B and disclosed financials.

M&A TRANSACTION · 2021

Medline Industries acquired by Blackstone, Carlyle and Hellman & Friedman

$34.00B· 15.5x EBITDA· 1.70x revenue

Target

Medline Industries

Acquirer

Blackstone, Carlyle and Hellman & Friedman

Private Equity buyer

Disclosed financials at time of acquisition

Revenue

$20200.0M

EBITDA

$2200.0M

Deal Value

$34.00B

EV/EBITDA

15.5x

Context

This $34.00B acquisition of Medline Industries by Blackstone, Carlyle and Hellman & Friedman sits in the medical devices sub-vertical. The 15.5x EBITDA multiple paid in 2021 can be compared against the population median for medical devices transactions of similar size on our Medical Devices valuation hub. Blackstone, Carlyle and Hellman & Friedman is acquiring as a private equity buyer; see how PE acquirers typically price medical devices businesses on our Medical Devices PE buyer-pool page.

Source

Data sourced from Press releases and press reporting. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own medical devices

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the Medline Industries acquisition.

Citation: ExitValue.ai. (2021). Medline Industries acquired by Blackstone, Carlyle and Hellman & Friedman. https://exitvalue.ai/deals/medline-industries-acquired-by-blackstone-carlyle-and-hellman-friedman-hc-2021-0097